Table 2.

Comparison of the NIHSS, ADL, mRS and HAMA, HAMD at different time points in 2 groups.

	Experimental group (N = 94)	Control group (N = 77)	P value
Primary outcomes
ADL
Before treatment	34.36 ± 6.402	33.51 ± 5.853	.368
On the days 14	53.72 ± 8.948	49.48 ± 7.805	.001
On the months 3	67.45 ± 12.109	58.64 ± 9.306	<.001
On the months 6	85.85 ± 10.540	80.13 ± 13.002	.002
mRS
Before treatment	3.98 ± 0.145	3.96 ± 0.195	.498
On the days 14	3.22 ± 0.571	3.40 ± 0.494	.031
On the months 3	2.64 ± 0.526	3.06 ± 0.439	<.001
On the months 6	1.57 ± 1.042	1.99 ± 0.803	.005
Secondary outcomes
NIHSS
Before treatment	17.07 ± 2.263	17.10 ± 2.326	.934
On the days 14	11.90 ± 2.379	12.73 ± 2.315	.024
On the month 1	6.59 ± 3.244	7.65 ± 3.417	.039
HAMA
On the months 3	15 (16.0%)	26 (33.8%)	.007
On the months 6	17 (18.1%)	29 (37.7%)	.005
HAMD
On the months 3	9 (9.6%)	19 (24.7%)	.012
On the months 6	14 (14.9%)	25 (32.5%)	.010
Safety outcomes
Primary intracranial hemorrhage	0	0
Gastrointestinal hemorrhage	2 (2.1%)	3 (3.9%)	.659
Nasal and gum bleeding	5 (5.3%)	4 (5.2%)	1.000
Subcutaneous hemorrhage	0	0

ADL = Barthel Index of activities of daily living, HAMA = Hamilton Anxiety Scale, HAMD = Hamilton Depression Scale, mRS = Modified Rankin Scale, NIHSS = National Institutes of Health Stroke Scale.